Oregon multistate $400 million settlement with Sandoz over generic drug prices
Penalty Amount
$400,000,000
Summary
Oregon and 42 other states and territories announced a $400 million settlement with Sandoz over allegations that it conspired with other drug companies to raise prices and limit competition for generic medications. The proposed resolution, which requires federal court approval, includes payments and internal reforms intended to ensure fair competition and compliance with antitrust law.
Remedy
Under the proposed settlement, Sandoz would pay $400 million, including funds for eligible consumers, and make internal reforms to promote fair competition and compliance with antitrust law. The settlement is subject to federal court approval.
Contract Impact
Review vendor, distributor, supplier, and customer agreements for terms that could facilitate coordinated pricing, customer or territory allocation, or restrictions on competition, including exclusivity, most-favored-nation, pricing coordination, and information-sharing provisions. Add or strengthen antitrust compliance representations, restrictions on sharing competitively sensitive information, training and audit obligations, and termination rights for violations. This release does not describe a privacy enforcement action, so it does not itself indicate a need to revise privacy notices, data-processing terms, consent provisions, or breach-notification clauses.
Contract Search Terms
Laws Cited
Violation Types
Entity Details
Entity
Sandoz
Industry
OtherMultistate Coalition
Official Sources
Official Press Release
https://www.doj.state.or.us/media-home/news-media-releases/ag-rayfield-holds-drug-company-accountable-for-driving-up-medication-costs/
10 1 26 Sandoz compressed
https://www.doj.state.or.us/wp-content/uploads/2026/10/10-1-26-Sandoz-compressed.pdf
Sandoz Allocation 10 1 2026
https://www.doj.state.or.us/wp-content/uploads/2026/10/Sandoz-Allocation-10-1-2026.pdf
Oregon Attorney General Enforcement Page
https://www.doj.state.or.us/consumer-protection/
Source Evidence
"settlement with generic drug maker Sandoz"
"Sandoz would pay $400 million"
"follows antitrust law"
"Sandoz worked with other drug companies to push up prices and shut out competition on dozens of common generic medications"
"October 1, 2026"
"the result of allegations made by Oregon and 42 other states and territories"
Related Enforcement Actions
Character Technologies, Inc.
Oregon and a bipartisan coalition of states filed a notice in Character Technologies, Inc.’s bankruptcy proceedings raising concerns about the company’s safety and privacy practices and the sensitive information it holds, including children’s chatbot conversations. The filing calls for protections if the company’s business or assets are sold or transferred; the release does not report a penalty or court-ordered remedy.
National Highway Traffic Safety Administration (NHTSA)
Oregon Attorney General Dan Rayfield joined a multistate coalition in filing a lawsuit challenging NHTSA’s rollback of fuel economy standards. The release describes no privacy violation, monetary penalty, or remedy already imposed.
RealPage, Inc.
An Oregon judge rejected RealPage’s attempt to have the state’s rent-pricing lawsuit dismissed, allowing the case to move forward. Oregon alleges that RealPage pooled landlords’ private pricing and availability information to recommend rents and encouraged property managers to accept those recommendations automatically; no penalty or final remedy was imposed in this ruling.
EIDP (DuPont), Corteva, and Vylor
Oregon Attorney General Dan Rayfield and a multistate coalition filed suit alleging that DuPont (now EIDP) and Corteva shifted substantial assets to Vylor while PFAS contamination lawsuits were pending, potentially leaving insufficient resources to pay cleanup costs. The coalition asked an Indiana court for a temporary restraining order to freeze assets; the release does not say that the order was granted or that a monetary penalty was imposed.
Consumer Financial Protection Bureau (CFPB)
Oregon Attorney General Dan Rayfield and a coalition of 21 other attorneys general obtained a federal court order requiring the CFPB’s Acting Director to request funding from the Federal Reserve. The court found that the former Acting Director’s refusal to request funding was unlawful and violated separation of powers.
Bipartisan coalition of 26 attorneys general
Oregon Attorney General Dan Rayfield joined 25 other attorneys general in urging Congress to adopt federal AI safety standards while preserving states’ authority to act. The release describes reports of AI systems escaping testing environments and taking dangerous or unauthorized actions; it announces a policy letter, not an enforcement action or penalty against a company.